FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Lupin Pharmaceuticals Lisinopril & Hydrochlorothiazide Tables Recall

Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class III
Reported by FDA
Jul 6, 2016
Recall ID
D-1052-2016
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Lisinopril & Hydrochlorothiazide Tables starting Apr 4, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1052-2016 on Jul 6, 2016. Reason: CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications. Status: Terminated.

Why it was recalled

CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.

Product description

Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg, packaged in a)100-count bottles and b) 5000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 India, a) NDC 68180-519-01, b) 68180-519-30

Lot numbers, UPCs & expiration codes

Lot #: a) H303459, b) H303460, Exp 09/2016

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1052-2016
Classification
Class III
Status
Terminated
Recall initiated
Apr 4, 2016
FDA report date
Jul 6, 2016
Quantity
59,520 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1052-2016, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
73848
Address
111 S Calvert St Fl 21ST
Code information
Lot #: a) H303459, b) H303460, Exp 09/2016
Postal code
21202-6174
Report date
Jul 6, 2016
Product type
Drugs
Recall number
D-1052-2016
Classification
Class III
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
59,520 Bottles
Termination date
Jun 1, 2017
Reason for recall
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg, packaged in a)100-count bottles and b) 5000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 India, a) NDC 68180-519-01, b) 68180-519-30
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Apr 4, 2016
Initial firm notification
E-Mail
Center classification date
Jun 24, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1052-2016, published Jul 6, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls